| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 55 | 2025 | 819 | 7.840 |
Why?
|
| Evolution, Molecular | 65 | 2024 | 668 | 7.300 |
Why?
|
| Proteins | 40 | 2020 | 1040 | 6.040 |
Why?
|
| Protein Conformation | 35 | 2021 | 837 | 2.610 |
Why?
|
| Algorithms | 29 | 2024 | 1630 | 2.250 |
Why?
|
| Sequence Analysis, Protein | 10 | 2015 | 48 | 2.250 |
Why?
|
| Sequence Alignment | 22 | 2023 | 620 | 2.160 |
Why?
|
| Databases, Protein | 19 | 2015 | 56 | 1.840 |
Why?
|
| Escherichia coli | 7 | 2023 | 968 | 1.820 |
Why?
|
| Models, Molecular | 48 | 2021 | 1084 | 1.810 |
Why?
|
| Mutation, Missense | 14 | 2025 | 879 | 1.800 |
Why?
|
| Binding Sites | 32 | 2023 | 1305 | 1.790 |
Why?
|
| Mutation | 41 | 2024 | 5906 | 1.780 |
Why?
|
| Enzymes | 9 | 2013 | 51 | 1.680 |
Why?
|
| Tumor Suppressor Protein p53 | 10 | 2024 | 746 | 1.670 |
Why?
|
| Protein Interaction Mapping | 8 | 2014 | 86 | 1.630 |
Why?
|
| Software | 13 | 2025 | 687 | 1.590 |
Why?
|
| Genetic Variation | 13 | 2025 | 1505 | 1.580 |
Why?
|
| Receptors, G-Protein-Coupled | 7 | 2023 | 296 | 1.430 |
Why?
|
| Biological Evolution | 8 | 2023 | 227 | 1.420 |
Why?
|
| Phylogeny | 15 | 2023 | 686 | 1.310 |
Why?
|
| Amino Acid Substitution | 10 | 2025 | 398 | 1.300 |
Why?
|
| Phenotype | 20 | 2025 | 4271 | 1.280 |
Why?
|
| Neoplasms | 8 | 2022 | 2794 | 1.230 |
Why?
|
| Genetic Fitness | 6 | 2024 | 32 | 1.220 |
Why?
|
| Protein Interaction Maps | 3 | 2020 | 79 | 1.190 |
Why?
|
| Molecular Sequence Annotation | 8 | 2019 | 148 | 1.140 |
Why?
|
| Models, Genetic | 13 | 2022 | 761 | 1.060 |
Why?
|
| Amino Acid Sequence | 38 | 2021 | 2717 | 1.040 |
Why?
|
| Receptors, Metabotropic Glutamate | 3 | 2023 | 45 | 1.030 |
Why?
|
| Protein Binding | 18 | 2018 | 1756 | 0.910 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 798 | 0.910 |
Why?
|
| Machine Learning | 4 | 2025 | 250 | 0.890 |
Why?
|
| GTP-Binding Proteins | 10 | 2019 | 179 | 0.880 |
Why?
|
| Proteome | 5 | 2021 | 246 | 0.870 |
Why?
|
| beta-Arrestins | 4 | 2021 | 30 | 0.850 |
Why?
|
| Computer Simulation | 10 | 2021 | 650 | 0.820 |
Why?
|
| Receptors, Dopamine D2 | 4 | 2019 | 43 | 0.800 |
Why?
|
| Humans | 114 | 2025 | 125138 | 0.790 |
Why?
|
| Structure-Activity Relationship | 17 | 2021 | 581 | 0.780 |
Why?
|
| Mobile Applications | 1 | 2023 | 88 | 0.770 |
Why?
|
| Calculi | 1 | 2022 | 14 | 0.770 |
Why?
|
| Protein Engineering | 5 | 2019 | 72 | 0.740 |
Why?
|
| Autism Spectrum Disorder | 3 | 2021 | 392 | 0.730 |
Why?
|
| Apolipoprotein E2 | 1 | 2020 | 13 | 0.710 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2025 | 2656 | 0.700 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 45 | 0.700 |
Why?
|
| Proteomics | 5 | 2013 | 506 | 0.690 |
Why?
|
| Head and Neck Neoplasms | 5 | 2023 | 503 | 0.690 |
Why?
|
| Medical Subject Headings | 1 | 2020 | 1 | 0.680 |
Why?
|
| Publications | 1 | 2020 | 33 | 0.660 |
Why?
|
| Escherichia coli Proteins | 1 | 2022 | 303 | 0.660 |
Why?
|
| Signal Transduction | 20 | 2019 | 4597 | 0.640 |
Why?
|
| Databases, Genetic | 10 | 2025 | 475 | 0.640 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2022 | 358 | 0.640 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2024 | 1985 | 0.630 |
Why?
|
| Sex Factors | 1 | 2023 | 1275 | 0.630 |
Why?
|
| Genotype | 6 | 2022 | 2570 | 0.630 |
Why?
|
| NIMA-Related Kinases | 1 | 2018 | 13 | 0.610 |
Why?
|
| Molecular Sequence Data | 27 | 2014 | 3898 | 0.610 |
Why?
|
| Germ-Line Mutation | 3 | 2018 | 343 | 0.600 |
Why?
|
| Viral Vaccines | 1 | 2021 | 337 | 0.600 |
Why?
|
| Ligands | 12 | 2023 | 538 | 0.590 |
Why?
|
| Precision Medicine | 4 | 2019 | 321 | 0.580 |
Why?
|
| HEK293 Cells | 14 | 2019 | 738 | 0.570 |
Why?
|
| Autistic Disorder | 1 | 2021 | 349 | 0.570 |
Why?
|
| Serine Endopeptidases | 3 | 2014 | 182 | 0.550 |
Why?
|
| Genetic Testing | 3 | 2025 | 1016 | 0.550 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2014 | 658 | 0.550 |
Why?
|
| Codon | 1 | 2017 | 98 | 0.540 |
Why?
|
| Receptors, Adrenergic, beta-2 | 8 | 2019 | 84 | 0.540 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 805 | 0.530 |
Why?
|
| Genome, Human | 3 | 2024 | 1293 | 0.530 |
Why?
|
| Sequence Analysis, DNA | 3 | 2019 | 1762 | 0.530 |
Why?
|
| RNA | 1 | 2020 | 576 | 0.520 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 2527 | 0.520 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2016 | 669 | 0.500 |
Why?
|
| Protein Folding | 9 | 2019 | 216 | 0.480 |
Why?
|
| Intellectual Disability | 4 | 2025 | 1054 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2025 | 3176 | 0.470 |
Why?
|
| Amino Acid Motifs | 7 | 2008 | 200 | 0.460 |
Why?
|
| Open Reading Frames | 1 | 2014 | 212 | 0.440 |
Why?
|
| Animals | 47 | 2024 | 34304 | 0.440 |
Why?
|
| Genomics | 8 | 2015 | 1520 | 0.430 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2025 | 501 | 0.430 |
Why?
|
| Genetics, Medical | 1 | 2014 | 119 | 0.430 |
Why?
|
| Structural Homology, Protein | 3 | 2009 | 26 | 0.420 |
Why?
|
| Bacterial Proteins | 4 | 2014 | 887 | 0.420 |
Why?
|
| Selection, Genetic | 3 | 2022 | 154 | 0.420 |
Why?
|
| Gene Frequency | 4 | 2025 | 729 | 0.400 |
Why?
|
| Protein Structure, Secondary | 16 | 2014 | 238 | 0.400 |
Why?
|
| Conserved Sequence | 9 | 2020 | 290 | 0.390 |
Why?
|
| Models, Biological | 6 | 2008 | 1465 | 0.390 |
Why?
|
| ROC Curve | 4 | 2025 | 571 | 0.390 |
Why?
|
| RGS Proteins | 5 | 2009 | 47 | 0.390 |
Why?
|
| Cluster Analysis | 8 | 2019 | 402 | 0.380 |
Why?
|
| Homeostasis | 1 | 2016 | 704 | 0.380 |
Why?
|
| Rec A Recombinases | 1 | 2011 | 26 | 0.370 |
Why?
|
| Calmodulin | 2 | 2024 | 230 | 0.370 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 1708 | 0.370 |
Why?
|
| Epistasis, Genetic | 3 | 2017 | 94 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2371 | 0.350 |
Why?
|
| Breast Neoplasms | 5 | 2024 | 2518 | 0.350 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1654 | 0.350 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 3422 | 0.340 |
Why?
|
| Reproducibility of Results | 8 | 2022 | 2878 | 0.330 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 210 | 0.330 |
Why?
|
| Brain | 3 | 2020 | 3015 | 0.330 |
Why?
|
| Phosphorylation | 10 | 2025 | 1640 | 0.320 |
Why?
|
| Thermodynamics | 5 | 2025 | 145 | 0.310 |
Why?
|
| Protein Structure, Tertiary | 14 | 2014 | 768 | 0.310 |
Why?
|
| Receptors, Cell Surface | 4 | 2018 | 477 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2025 | 92 | 0.300 |
Why?
|
| Artificial Intelligence | 4 | 2008 | 245 | 0.300 |
Why?
|
| Gene Regulatory Networks | 3 | 2017 | 365 | 0.300 |
Why?
|
| Substrate Specificity | 3 | 2014 | 295 | 0.300 |
Why?
|
| Allosteric Site | 2 | 2017 | 11 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2025 | 108 | 0.300 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2016 | 319 | 0.300 |
Why?
|
| Drug Repositioning | 2 | 2020 | 23 | 0.290 |
Why?
|
| Protein Structure, Quaternary | 4 | 2010 | 98 | 0.290 |
Why?
|
| Models, Statistical | 6 | 2010 | 470 | 0.290 |
Why?
|
| Membrane Proteins | 6 | 2019 | 1538 | 0.290 |
Why?
|
| Database Management Systems | 1 | 2007 | 31 | 0.280 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 3 | 2002 | 28 | 0.280 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 780 | 0.280 |
Why?
|
| Information Storage and Retrieval | 1 | 2007 | 57 | 0.280 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 459 | 0.270 |
Why?
|
| Mutation Rate | 2 | 2024 | 67 | 0.260 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 664 | 0.260 |
Why?
|
| Cisplatin | 3 | 2023 | 250 | 0.260 |
Why?
|
| Exome | 3 | 2024 | 1034 | 0.260 |
Why?
|
| Antigens, Protozoan | 2 | 2017 | 66 | 0.250 |
Why?
|
| Water | 1 | 2007 | 186 | 0.250 |
Why?
|
| A Kinase Anchor Proteins | 2 | 2018 | 18 | 0.250 |
Why?
|
| Plasmodium falciparum | 2 | 2017 | 67 | 0.250 |
Why?
|
| Receptors, Estrogen | 2 | 2006 | 794 | 0.250 |
Why?
|
| Transcription Factors | 5 | 2024 | 2603 | 0.250 |
Why?
|
| Amino Acids | 5 | 2016 | 668 | 0.240 |
Why?
|
| DNA-Binding Proteins | 8 | 2020 | 2061 | 0.240 |
Why?
|
| Cell Physiological Phenomena | 1 | 2005 | 16 | 0.240 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2025 | 9 | 0.240 |
Why?
|
| Biophysics | 1 | 2005 | 50 | 0.240 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2016 | 140 | 0.240 |
Why?
|
| Protein Stability | 6 | 2024 | 161 | 0.230 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2024 | 66 | 0.230 |
Why?
|
| Dimerization | 7 | 2009 | 144 | 0.230 |
Why?
|
| DNA Mutational Analysis | 6 | 2011 | 810 | 0.230 |
Why?
|
| Ribonucleotides | 1 | 2024 | 36 | 0.220 |
Why?
|
| RNA Stability | 1 | 2024 | 84 | 0.220 |
Why?
|
| Hyperparathyroidism | 1 | 2024 | 25 | 0.220 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 68 | 0.220 |
Why?
|
| Cell Membrane | 6 | 2013 | 464 | 0.220 |
Why?
|
| Models, Chemical | 4 | 2011 | 86 | 0.220 |
Why?
|
| DNA | 3 | 2020 | 1621 | 0.220 |
Why?
|
| Osteogenesis Imperfecta | 2 | 2017 | 150 | 0.220 |
Why?
|
| Supervised Machine Learning | 1 | 2023 | 10 | 0.210 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 420 | 0.210 |
Why?
|
| Base Sequence | 6 | 2018 | 3109 | 0.210 |
Why?
|
| Genome, Viral | 1 | 2024 | 165 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 210 | 0.210 |
Why?
|
| Zinc | 3 | 1999 | 135 | 0.200 |
Why?
|
| Probability | 1 | 2003 | 318 | 0.200 |
Why?
|
| Calcium | 4 | 2021 | 1105 | 0.200 |
Why?
|
| Guanosine Triphosphate | 2 | 2000 | 51 | 0.200 |
Why?
|
| Rhodopsin | 4 | 2009 | 64 | 0.200 |
Why?
|
| Female | 23 | 2025 | 66719 | 0.200 |
Why?
|
| Systems Integration | 2 | 2016 | 27 | 0.200 |
Why?
|
| RNA Splicing | 1 | 2024 | 230 | 0.200 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 1694 | 0.200 |
Why?
|
| Data Interpretation, Statistical | 1 | 2023 | 231 | 0.190 |
Why?
|
| Virus Replication | 2 | 2024 | 607 | 0.190 |
Why?
|
| Colistin | 1 | 2022 | 30 | 0.190 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2002 | 10 | 0.190 |
Why?
|
| Loss of Heterozygosity | 2 | 2019 | 130 | 0.190 |
Why?
|
| Rare Diseases | 1 | 2024 | 191 | 0.190 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 61 | 0.190 |
Why?
|
| RNA, Viral | 1 | 2024 | 537 | 0.190 |
Why?
|
| Cloning, Molecular | 3 | 2013 | 898 | 0.190 |
Why?
|
| Nucleic Acids | 1 | 2021 | 24 | 0.190 |
Why?
|
| Oncogenes | 1 | 2022 | 176 | 0.190 |
Why?
|
| Mice | 15 | 2024 | 17739 | 0.190 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2021 | 37 | 0.180 |
Why?
|
| Arrestins | 2 | 2015 | 28 | 0.180 |
Why?
|
| Apraxias | 1 | 2021 | 11 | 0.180 |
Why?
|
| Xanthines | 1 | 2021 | 14 | 0.180 |
Why?
|
| Glycoside Hydrolases | 1 | 2021 | 17 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1273 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 348 | 0.180 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2020 | 19 | 0.170 |
Why?
|
| Sensitivity and Specificity | 5 | 2007 | 2056 | 0.170 |
Why?
|
| Yeasts | 2 | 2019 | 43 | 0.170 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 587 | 0.170 |
Why?
|
| Internet | 3 | 2009 | 375 | 0.170 |
Why?
|
| Antimalarials | 2 | 2017 | 40 | 0.170 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 1714 | 0.170 |
Why?
|
| DNA Repair | 3 | 2021 | 591 | 0.170 |
Why?
|
| Drosophila | 3 | 2020 | 776 | 0.170 |
Why?
|
| Nucleotides | 1 | 2020 | 91 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 825 | 0.160 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 126 | 0.160 |
Why?
|
| Acetylglucosaminidase | 1 | 2019 | 12 | 0.160 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2019 | 14 | 0.160 |
Why?
|
| Data Mining | 1 | 2020 | 51 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 129 | 0.160 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2019 | 36 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 45 | 0.160 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 114 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 102 | 0.160 |
Why?
|
| Iron-Binding Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
| Diffusion | 1 | 2019 | 57 | 0.160 |
Why?
|
| Likelihood Functions | 2 | 2010 | 114 | 0.160 |
Why?
|
| Circular Dichroism | 3 | 2025 | 86 | 0.160 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 71 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 791 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2023 | 1133 | 0.160 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 69 | 0.160 |
Why?
|
| Serotonin | 2 | 2019 | 212 | 0.150 |
Why?
|
| Autoantigens | 1 | 2019 | 118 | 0.150 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2018 | 3 | 0.150 |
Why?
|
| Methyltransferases | 1 | 2019 | 72 | 0.150 |
Why?
|
| Homozygote | 1 | 2020 | 547 | 0.150 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2018 | 3 | 0.150 |
Why?
|
| HCT116 Cells | 1 | 2018 | 55 | 0.150 |
Why?
|
| CRISPR-Cas Systems | 2 | 2018 | 256 | 0.150 |
Why?
|
| PubMed | 1 | 2018 | 20 | 0.150 |
Why?
|
| Heterozygote | 1 | 2020 | 672 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2018 | 19 | 0.150 |
Why?
|
| Dopamine | 2 | 2019 | 279 | 0.150 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 26 | 0.150 |
Why?
|
| Hepatectomy | 1 | 2019 | 112 | 0.150 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 147 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2018 | 19 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 158 | 0.150 |
Why?
|
| Warfarin | 1 | 2019 | 118 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3756 | 0.150 |
Why?
|
| Natural Language Processing | 1 | 2018 | 58 | 0.150 |
Why?
|
| Chloroquine | 1 | 2017 | 31 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 734 | 0.140 |
Why?
|
| Anoctamins | 1 | 2017 | 13 | 0.140 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 11 | 0.140 |
Why?
|
| Automation | 2 | 2012 | 64 | 0.140 |
Why?
|
| Forecasting | 4 | 2013 | 352 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 4 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 260 | 0.140 |
Why?
|
| Databases, Factual | 4 | 2016 | 1172 | 0.140 |
Why?
|
| Mutagenesis | 6 | 2015 | 345 | 0.140 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2017 | 5 | 0.140 |
Why?
|
| Pyruvate Kinase | 1 | 2017 | 9 | 0.140 |
Why?
|
| Pattern Recognition, Automated | 2 | 2008 | 49 | 0.140 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 34 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 228 | 0.130 |
Why?
|
| Ribonucleotide Reductases | 2 | 2009 | 10 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 158 | 0.130 |
Why?
|
| Phosphotransferases | 1 | 2017 | 41 | 0.130 |
Why?
|
| Zellweger Syndrome | 1 | 2017 | 15 | 0.130 |
Why?
|
| Germ Cells | 1 | 2018 | 196 | 0.130 |
Why?
|
| Norepinephrine | 1 | 2017 | 171 | 0.130 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2017 | 38 | 0.130 |
Why?
|
| Mitochondrial Diseases | 1 | 2018 | 132 | 0.130 |
Why?
|
| Job Syndrome | 1 | 2016 | 17 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 319 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 165 | 0.130 |
Why?
|
| Haploinsufficiency | 1 | 2018 | 258 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2019 | 312 | 0.130 |
Why?
|
| Molecular Conformation | 3 | 2006 | 106 | 0.130 |
Why?
|
| Toxicogenetics | 1 | 2016 | 2 | 0.130 |
Why?
|
| Epinephrine | 1 | 2017 | 177 | 0.130 |
Why?
|
| Benchmarking | 1 | 2017 | 137 | 0.130 |
Why?
|
| Gene Editing | 1 | 2018 | 186 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 217 | 0.130 |
Why?
|
| Catalytic Domain | 4 | 2021 | 162 | 0.130 |
Why?
|
| Knowledge Bases | 1 | 2016 | 36 | 0.120 |
Why?
|
| Monte Carlo Method | 2 | 2006 | 95 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2021 | 767 | 0.120 |
Why?
|
| Calcium Signaling | 1 | 2017 | 244 | 0.120 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2024 | 429 | 0.120 |
Why?
|
| Allosteric Regulation | 2 | 2017 | 48 | 0.120 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 1284 | 0.120 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 234 | 0.120 |
Why?
|
| Male | 13 | 2025 | 61465 | 0.120 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 19 | 0.120 |
Why?
|
| Entropy | 2 | 2005 | 26 | 0.120 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 57 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 1400 | 0.120 |
Why?
|
| Type C Phospholipases | 1 | 2014 | 28 | 0.120 |
Why?
|
| Rett Syndrome | 2 | 2013 | 292 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 218 | 0.110 |
Why?
|
| Data Compression | 1 | 2014 | 12 | 0.110 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2014 | 18 | 0.110 |
Why?
|
| Molecular Structure | 2 | 2006 | 294 | 0.110 |
Why?
|
| Gene Deletion | 4 | 2018 | 793 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 248 | 0.110 |
Why?
|
| Imidazoles | 1 | 2015 | 206 | 0.110 |
Why?
|
| Hydroxylation | 1 | 2014 | 48 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2018 | 963 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 705 | 0.110 |
Why?
|
| Piperazines | 1 | 2015 | 241 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 578 | 0.110 |
Why?
|
| Acyltransferases | 1 | 2013 | 44 | 0.110 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2013 | 37 | 0.110 |
Why?
|
| Proteoglycans | 1 | 2014 | 88 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 248 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 214 | 0.110 |
Why?
|
| Genetics, Population | 1 | 2014 | 188 | 0.110 |
Why?
|
| Crystallography, X-Ray | 3 | 2024 | 358 | 0.110 |
Why?
|
| Mitochondria | 1 | 2018 | 680 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 314 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 81 | 0.100 |
Why?
|
| Feedback | 1 | 2014 | 162 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 576 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 625 | 0.100 |
Why?
|
| ras Proteins | 1 | 2013 | 139 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 715 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2014 | 155 | 0.100 |
Why?
|
| Seizures | 1 | 2018 | 869 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2013 | 212 | 0.100 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 2 | 2009 | 5 | 0.100 |
Why?
|
| Molecular Chaperones | 2 | 2014 | 168 | 0.100 |
Why?
|
| Cell Line | 8 | 2013 | 2756 | 0.100 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 2 | 2009 | 5 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1339 | 0.100 |
Why?
|
| DNA Primers | 1 | 2013 | 657 | 0.100 |
Why?
|
| Collagen | 1 | 2014 | 317 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2013 | 80 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2005 | 376 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 151 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1066 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1989 | 295 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2012 | 157 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2012 | 134 | 0.090 |
Why?
|
| Desmosterol | 1 | 2011 | 3 | 0.090 |
Why?
|
| HeLa Cells | 3 | 2013 | 808 | 0.090 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2011 | 8 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2011 | 5 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2011 | 7 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 413 | 0.090 |
Why?
|
| Actins | 1 | 2013 | 346 | 0.090 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2011 | 20 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 819 | 0.090 |
Why?
|
| Homologous Recombination | 1 | 2011 | 93 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1362 | 0.090 |
Why?
|
| Biochemistry | 1 | 2010 | 11 | 0.090 |
Why?
|
| Hyperammonemia | 1 | 2011 | 63 | 0.090 |
Why?
|
| Kinetics | 4 | 2017 | 1330 | 0.090 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2017 | 94 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2012 | 256 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 544 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 635 | 0.080 |
Why?
|
| Point Mutation | 5 | 2005 | 351 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 725 | 0.080 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 310 | 0.080 |
Why?
|
| Receptors, Complement | 2 | 2000 | 32 | 0.080 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2010 | 62 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 690 | 0.080 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 714 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 860 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 395 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2009 | 27 | 0.080 |
Why?
|
| Isoproterenol | 3 | 2017 | 104 | 0.080 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 48 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 2010 | 125 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 781 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2014 | 516 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1316 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1819 | 0.080 |
Why?
|
| Response Elements | 2 | 2005 | 96 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 978 | 0.070 |
Why?
|
| Templates, Genetic | 1 | 2008 | 97 | 0.070 |
Why?
|
| Protein Domains | 2 | 2021 | 236 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 212 | 0.070 |
Why?
|
| Genome, Bacterial | 2 | 2019 | 183 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2014 | 165 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 1022 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2000 | 430 | 0.070 |
Why?
|
| beta-Endorphin | 1 | 1987 | 10 | 0.070 |
Why?
|
| Cattle | 3 | 2005 | 567 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2025 | 14155 | 0.070 |
Why?
|
| Cyclic AMP | 3 | 2018 | 247 | 0.070 |
Why?
|
| Directed Molecular Evolution | 1 | 2006 | 11 | 0.070 |
Why?
|
| Vocabulary, Controlled | 1 | 2006 | 12 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2006 | 363 | 0.070 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 2006 | 2 | 0.070 |
Why?
|
| Transducin | 2 | 1997 | 31 | 0.070 |
Why?
|
| Antigens, Nuclear | 1 | 2007 | 61 | 0.070 |
Why?
|
| Anion Transport Proteins | 1 | 2006 | 30 | 0.070 |
Why?
|
| Programming Languages | 1 | 2006 | 19 | 0.070 |
Why?
|
| Computer Graphics | 1 | 2006 | 38 | 0.070 |
Why?
|
| Rod Opsins | 2 | 2003 | 16 | 0.060 |
Why?
|
| Citrate (si)-Synthase | 1 | 2006 | 17 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2017 | 771 | 0.060 |
Why?
|
| Photoaffinity Labels | 1 | 2006 | 6 | 0.060 |
Why?
|
| Genes | 1 | 2006 | 447 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2019 | 777 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 339 | 0.060 |
Why?
|
| Receptor Cross-Talk | 1 | 2005 | 38 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1958 | 0.060 |
Why?
|
| Neurons | 3 | 2018 | 1933 | 0.060 |
Why?
|
| Telomere | 1 | 2007 | 220 | 0.060 |
Why?
|
| Biological Transport | 1 | 2006 | 355 | 0.060 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Rats | 4 | 2014 | 3728 | 0.060 |
Why?
|
| Nuclear Pore | 1 | 2004 | 10 | 0.060 |
Why?
|
| Nucleic Acid Conformation | 1 | 2005 | 186 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2006 | 331 | 0.060 |
Why?
|
| Gene Expression | 3 | 2015 | 1554 | 0.060 |
Why?
|
| RNA-Binding Motifs | 1 | 2024 | 3 | 0.060 |
Why?
|
| Cell Survival | 2 | 2018 | 820 | 0.060 |
Why?
|
| Zebrafish | 2 | 2024 | 380 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2018 | 404 | 0.060 |
Why?
|
| Photochemistry | 1 | 2003 | 22 | 0.060 |
Why?
|
| Adult | 6 | 2024 | 29470 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 914 | 0.050 |
Why?
|
| Tryptophan | 1 | 2003 | 91 | 0.050 |
Why?
|
| Guanosine Diphosphate | 3 | 2001 | 13 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 28 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4685 | 0.050 |
Why?
|
| Middle Aged | 5 | 2024 | 26688 | 0.050 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2003 | 40 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 1130 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 2051 | 0.050 |
Why?
|
| Leucine | 1 | 2003 | 310 | 0.050 |
Why?
|
| Fungal Proteins | 2 | 2019 | 134 | 0.050 |
Why?
|
| Adolescent | 4 | 2025 | 19424 | 0.050 |
Why?
|
| Statistical Distributions | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Oxytocin | 1 | 2002 | 19 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 114 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2004 | 680 | 0.050 |
Why?
|
| Adiposity | 1 | 2023 | 190 | 0.050 |
Why?
|
| Guanylate Cyclase | 1 | 2002 | 38 | 0.050 |
Why?
|
| Peptides | 1 | 2005 | 812 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 387 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 772 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 372 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 2016 | 145 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIbeta Subunit | 1 | 2021 | 2 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2010 | 4824 | 0.050 |
Why?
|
| Lysine | 1 | 2002 | 200 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 110 | 0.040 |
Why?
|
| Multigene Family | 1 | 2002 | 301 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2017 | 1086 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2019 | 3044 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 326 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6543 | 0.040 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2000 | 59 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2000 | 12 | 0.040 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2000 | 38 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2017 | 626 | 0.040 |
Why?
|
| Child | 4 | 2025 | 24620 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2000 | 64 | 0.040 |
Why?
|
| Genome, Fungal | 1 | 2019 | 32 | 0.040 |
Why?
|
| Cystathionine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 1999 | 1 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 171 | 0.040 |
Why?
|
| Receptors, Opioid, mu | 1 | 2019 | 30 | 0.040 |
Why?
|
| Unsupervised Machine Learning | 1 | 2019 | 13 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2019 | 167 | 0.040 |
Why?
|
| Locomotion | 1 | 2019 | 67 | 0.040 |
Why?
|
| Memory, Long-Term | 1 | 2019 | 40 | 0.040 |
Why?
|
| Candida albicans | 1 | 2019 | 76 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 670 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2019 | 140 | 0.040 |
Why?
|
| X Chromosome | 1 | 2000 | 338 | 0.040 |
Why?
|
| Stem Cells | 1 | 2004 | 710 | 0.040 |
Why?
|
| Biofilms | 1 | 2019 | 82 | 0.040 |
Why?
|
| Homocysteine | 1 | 2019 | 115 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 19666 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 352 | 0.040 |
Why?
|
| beta-Arrestin 2 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2377 | 0.040 |
Why?
|
| Retina | 1 | 2002 | 452 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 876 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 1203 | 0.040 |
Why?
|
| Melatonin | 1 | 2018 | 27 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2018 | 23 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2018 | 26 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 162 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 174 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2018 | 128 | 0.040 |
Why?
|
| Paraplegia | 1 | 2018 | 91 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 447 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 126 | 0.040 |
Why?
|
| Pedigree | 2 | 2018 | 1610 | 0.040 |
Why?
|
| Infant | 3 | 2025 | 12611 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 77 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 287 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 145 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 283 | 0.040 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 48 | 0.040 |
Why?
|
| COS Cells | 3 | 2005 | 275 | 0.030 |
Why?
|
| Fructosediphosphates | 1 | 2017 | 3 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 681 | 0.030 |
Why?
|
| Estrenes | 1 | 2017 | 21 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 130 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2017 | 22 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 2017 | 17 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 37 | 0.030 |
Why?
|
| Boron Compounds | 1 | 2017 | 31 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2017 | 156 | 0.030 |
Why?
|
| Genome | 1 | 2000 | 481 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2017 | 256 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 112 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 2016 | 26 | 0.030 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2016 | 19 | 0.030 |
Why?
|
| Diterpenes | 1 | 2016 | 28 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 188 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 156 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 473 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1910 | 0.030 |
Why?
|
| Protein Transport | 2 | 2009 | 369 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2016 | 114 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 601 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1996 | 32 | 0.030 |
Why?
|
| Receptors, Steroid | 1 | 1997 | 273 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 184 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 121 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 362 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1684 | 0.030 |
Why?
|
| Antioxidants | 1 | 2018 | 355 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1996 | 119 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 281 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1996 | 120 | 0.030 |
Why?
|
| Crystallography | 1 | 2015 | 40 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 472 | 0.030 |
Why?
|
| Pregnancy | 2 | 2021 | 7221 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 409 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2015 | 93 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2014 | 34 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 81 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 9060 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2014 | 41 | 0.030 |
Why?
|
| Artemisinins | 1 | 2014 | 10 | 0.030 |
Why?
|
| Hemin | 1 | 2014 | 17 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2014 | 51 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 226 | 0.030 |
Why?
|
| Skeleton | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cyclophilins | 1 | 2014 | 19 | 0.030 |
Why?
|
| Palmitic Acids | 1 | 2013 | 14 | 0.030 |
Why?
|
| trans-Golgi Network | 1 | 2013 | 7 | 0.030 |
Why?
|
| Vinculin | 1 | 2013 | 4 | 0.030 |
Why?
|
| alpha Catenin | 1 | 2013 | 6 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 396 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 241 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 887 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 88 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2014 | 244 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2010 | 296 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1998 | 827 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 1999 | 29 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 92 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1078 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2013 | 44 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 471 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2016 | 674 | 0.030 |
Why?
|
| Schizosaccharomyces | 1 | 2013 | 66 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 122 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 163 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2014 | 307 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2014 | 204 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 101 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2013 | 143 | 0.030 |
Why?
|
| CHO Cells | 1 | 2013 | 169 | 0.030 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 16 | 0.030 |
Why?
|
| X-linked Nuclear Protein | 1 | 2013 | 18 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 157 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2013 | 50 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2013 | 26 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 30 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 74 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2013 | 23 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 422 | 0.030 |
Why?
|
| Sigma Factor | 1 | 2012 | 35 | 0.030 |
Why?
|
| Chikungunya virus | 1 | 2013 | 28 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2007 | 448 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2019 | 858 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 387 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3310 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2014 | 306 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 551 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2245 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 360 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2014 | 375 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 495 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2011 | 9 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 516 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2013 | 236 | 0.020 |
Why?
|
| West Nile virus | 1 | 2013 | 117 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1111 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2011 | 88 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1292 | 0.020 |
Why?
|
| Expert Systems | 2 | 1989 | 15 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 131 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2011 | 105 | 0.020 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2000 | 13 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 96 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3424 | 0.020 |
Why?
|
| Alprenolol | 1 | 2009 | 10 | 0.020 |
Why?
|
| Calnexin | 1 | 2009 | 13 | 0.020 |
Why?
|
| Brefeldin A | 1 | 2009 | 11 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2009 | 28 | 0.020 |
Why?
|
| Gene Library | 2 | 2000 | 218 | 0.020 |
Why?
|
| HIV-1 | 1 | 2013 | 464 | 0.020 |
Why?
|
| Dobutamine | 1 | 2009 | 56 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2009 | 57 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2009 | 73 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2010 | 162 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2009 | 194 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1006 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 626 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 3606 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 12276 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 802 | 0.020 |
Why?
|
| Histidine | 2 | 1999 | 73 | 0.020 |
Why?
|
| Hydrogen | 1 | 1987 | 41 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 238 | 0.020 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2007 | 9 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2414 | 0.020 |
Why?
|
| Ku Autoantigen | 1 | 2007 | 21 | 0.020 |
Why?
|
| Renilla | 1 | 2006 | 3 | 0.020 |
Why?
|
| Organic Anion Transporters | 1 | 2006 | 16 | 0.020 |
Why?
|
| Gerbillinae | 1 | 2006 | 55 | 0.020 |
Why?
|
| Myoglobin | 1 | 1987 | 107 | 0.020 |
Why?
|
| Surface Properties | 1 | 2007 | 81 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 97 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 586 | 0.020 |
Why?
|
| Iodocyanopindolol | 1 | 2005 | 3 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2005 | 28 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2005 | 40 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1592 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2005 | 11 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1242 | 0.020 |
Why?
|
| Carbon | 1 | 2006 | 91 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2005 | 45 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 100 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 80 | 0.010 |
Why?
|
| ran GTP-Binding Protein | 1 | 2004 | 28 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 118 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 513 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 331 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2005 | 381 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 187 | 0.010 |
Why?
|
| United States | 1 | 2019 | 10884 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 112 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2004 | 61 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2005 | 270 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 1077 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 945 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 312 | 0.010 |
Why?
|
| Receptors, Somatostatin | 1 | 2003 | 54 | 0.010 |
Why?
|
| Receptors, Vasopressin | 1 | 2002 | 11 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 4407 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2002 | 19 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2002 | 31 | 0.010 |
Why?
|
| Guanylate Cyclase-Activating Proteins | 1 | 2002 | 9 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 2002 | 83 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 96 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 309 | 0.010 |
Why?
|
| Photoreceptor Cells | 1 | 2002 | 91 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 395 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 210 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 472 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2002 | 116 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1981 | 221 | 0.010 |
Why?
|
| Exocytosis | 1 | 2000 | 63 | 0.010 |
Why?
|
| Pindolol | 1 | 1999 | 8 | 0.010 |
Why?
|
| Secretin | 1 | 1999 | 15 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 272 | 0.010 |
Why?
|
| Endocytosis | 1 | 2000 | 125 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 1999 | 19 | 0.010 |
Why?
|
| Complement C5a | 1 | 1999 | 25 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 192 | 0.010 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 1998 | 27 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1998 | 87 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 1998 | 58 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8275 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1704 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 463 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2000 | 351 | 0.010 |
Why?
|
| Retinaldehyde | 1 | 1997 | 8 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1997 | 17 | 0.010 |
Why?
|
| Fluorides | 1 | 1997 | 19 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 528 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 1 | 1997 | 48 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 772 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1996 | 45 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 6302 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2814 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2000 | 2907 | 0.010 |
Why?
|
| Rheology | 1 | 1981 | 33 | 0.000 |
Why?
|
| Rabbits | 1 | 1981 | 718 | 0.000 |
Why?
|
| Neutrophils | 1 | 1981 | 381 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1981 | 845 | 0.000 |
Why?
|